CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NAMS

Obicetrapib 10mg

Phase 2
NewAmsterdam Pharma Co N.V. (NAMS)

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Sep '26
NAMSPhase 2

Obicetrapib 10mg Phase 2 Est. Readout

Obicetrapib 10mg
Sep 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Antioxidant Absorption

View Full Landscape
Drug Information

Target Indication

Antioxidant Absorption

Clinical Trial

NCT06982508

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.